Free Trial
OTCMKTS:AOLS

Aeolus Pharmaceuticals (AOLS) Stock Price, News & Analysis

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)
Free AOLS Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsSEC Filings

About Aeolus Pharmaceuticals

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson's disease, as well as AEOL 20415 for treating infectious diseases. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.

AOLS Stock News Headlines

January 12, 2024 | investing.com
Aeolus Tyre Co Ltd (600469)
December 16, 2023 | bbc.com
Aeolus: Wind-mapping space laser is losing power
April 27, 2024 | True Market Insiders (Ad)
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
February 21, 2023 | yahoo.com
Aeolus Announces Third Quarter Fiscal Year 2015 Financial Results
October 8, 2022 | reuters.com
Aeolus Pharmaceuticals Inc
September 13, 2022 | uk.finance.yahoo.com
Aeolus Pharmaceuticals, Inc. (AOLS)
See More Headlines
Receive AOLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeolus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/14/2017
Today
4/27/2024
Fiscal Year End
9/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:AOLS
CUSIP
N/A
CIK
1261734
Web
www.aeoluspharma.com
Phone
(949) 481-9825
Fax
949-481-9829
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.55
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. John L. Mcmanus (Age 60)
    Chief Executive Officer and President
    Comp: $460.33k
  • Mr. Christopher Stanley
    Vice President of Operations

Key Competitors

View All Competitors

AOLS Stock Analysis - Frequently Asked Questions

How were Aeolus Pharmaceuticals' earnings last quarter?

Aeolus Pharmaceuticals, Inc. (OTCMKTS:AOLS) issued its earnings results on Monday, August, 14th. The biopharmaceutical company reported ($0.01) earnings per share for the quarter. The biopharmaceutical company earned $0.01 million during the quarter.

What other stocks do shareholders of Aeolus Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aeolus Pharmaceuticals investors own include iBio (IBIO), Myriad Genetics (MYGN), Synergy Pharmaceuticals (SGYP), Titan Pharmaceuticals (TTNP), ADOMANI (ADOM), Agritek (AGTK), Akers Biosciences (AKER), Argos Therapeutics (ARGSQ), Arena Pharmaceuticals (ARNA) and Biohaven (BHVN).

How do I buy shares of Aeolus Pharmaceuticals?

Shares of AOLS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AOLS) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Fed launches fourth dollar overhaul
Stansberry Research
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders